Clinical Trial Update: A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)

View source ↗

Summary

A UK real-world evidence study is evaluating guselkumab treatment for ulcerative colitis and Crohn's disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: Janssen-Cilag Ltd. | Conditions: Inflammatory Bowel Disease, Colitis, Ulcerative | Status: RECRUITING